These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37062125)

  • 1. Targeting telomerase utilizing zeolitic imidazole frameworks as non-viral gene delivery agents across different cancer cell types.
    Pyreddy S; Poddar A; Carraro F; Polash SA; Dekiwadia C; Murdoch B; Nasa Z; Reddy TS; Falcaro P; Shukla R
    Biomater Adv; 2023 Jun; 149():213420. PubMed ID: 37062125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zeolitic Imidazolate Framework-8 (ZIF-8) as a Drug Delivery Vehicle for the Transport and Release of Telomerase Inhibitor BIBR 1532.
    Zhang S; Li J; Yan L; You Y; Zhao F; Cheng J; Yang L; Sun Y; Chang Q; Liu R; Li Y
    Nanomaterials (Basel); 2023 May; 13(11):. PubMed ID: 37299682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
    Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
    Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
    Salimi-Jeda A; Badrzadeh F; Esghaei M; Abdoli A
    Cancer Treat Res Commun; 2021; 27():100323. PubMed ID: 33530025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system.
    Dai W; Xu X; Wang D; Wu J; Wang J
    Oncogene; 2019 May; 38(21):4110-4124. PubMed ID: 30696954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line.
    Song JS; Kim HP; Yoon WS; Lee KW; Kim MH; Kim KT; Kim HS; Kim YT
    Biosci Biotechnol Biochem; 2003 Nov; 67(11):2344-50. PubMed ID: 14646192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Scaled Zeolitic Imidazole Framework-8 as an Efficient Carrier for the Intracellular Delivery of RNase A in Cancer Treatment.
    Jia J; Zhang S; Wen K; Li Q
    Int J Nanomedicine; 2019; 14():9971-9981. PubMed ID: 31908453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
    Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL
    Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer.
    Song JS
    Biosci Biotechnol Biochem; 2004 Aug; 68(8):1634-9. PubMed ID: 15322345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale ATP-Responsive Zeolitic Imidazole Framework-90 as a General Platform for Cytosolic Protein Delivery and Genome Editing.
    Yang X; Tang Q; Jiang Y; Zhang M; Wang M; Mao L
    J Am Chem Soc; 2019 Mar; 141(9):3782-3786. PubMed ID: 30722666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
    Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
    Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors.
    Frolkis M; Fischer MB; Wang Z; Lebkowski JS; Chiu CP; Majumdar AS
    Cancer Gene Ther; 2003 Mar; 10(3):239-49. PubMed ID: 12637945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
    Ge L; Deng Z; Zhang Y; Shao W; Qiu Y; Cui D; Huang D
    Oncol Rep; 2011 Dec; 26(6):1487-95. PubMed ID: 21922145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino Acid-Coated Zeolitic Imidazolate Framework for Delivery of Genetic Material in Prostate Cancer Cell.
    Polash SA; Garlick-Trease K; Pyreddy S; Periasamy S; Bryant G; Shukla R
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in cancer as a diagnostic and therapeutic target.
    Kyo S; Takakura M; Inoue M
    Histol Histopathol; 2000 Jul; 15(3):813-24. PubMed ID: 10963125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.
    Jiang Z; Wang Y; Sun L; Yuan B; Tian Y; Xiang L; Li Y; Li Y; Li J; Wu A
    Biomaterials; 2019 Mar; 197():41-50. PubMed ID: 30640136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells.
    Kang X; Chen W; Kim RH; Kang MK; Park NH
    Oncogene; 2009 Jan; 28(4):565-74. PubMed ID: 19015635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses.
    Zhong X; Zhang Y; Tan L; Zheng T; Hou Y; Hong X; Du G; Chen X; Zhang Y; Sun X
    J Control Release; 2019 Apr; 300():81-92. PubMed ID: 30826373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor.
    Shi Z; Chen X; Zhang L; Ding S; Wang X; Lei Q; Fang W
    Biomater Sci; 2018 Sep; 6(10):2582-2590. PubMed ID: 30151542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the hTERT promoter by heat shock elements enhances the efficiency and specificity of cancer targeted gene therapy.
    Wang X; Zhou P; Sun X; Wei G; Zhang L; Wang H; Yao J; Jia P; Zheng J
    Int J Hyperthermia; 2016 May; 32(3):244-53. PubMed ID: 26981638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.